Evidence map›Paper›PMID 37459862›Full record

ArticlePhysics in medicine and biology2023

Radio-immune response modelling for spatially fractionated radiotherapy.

Young-Bin Cho, Nara Yoon, John H Suh, Jacob G Scott

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Physics in medicine and biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07595172 (A Phase I/II Clinical Trial of NALIRIFOX Combined With Adebrelimab and PULSAR as First-Line Treatment for Locally Advanced Unresectable or Metastatic Pancreatic Ductal Adenocarcinoma), which is not on this map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07595172 phase1 / phase2recruitingnot on this mapstarted 2026, after this paper: background citation

A Phase I/II Clinical Trial of NALIRIFOX Combined With Adebrelimab and PULSAR as First-Line Treatment for Locally Advanced Unresectable or Metastatic Pancreatic Ductal Adenocarcinoma

TypeinterventionalSponsorWest China HospitalRan2026 to 2029Enrolled55ConditionsPancreatic Ductal Adenocarcinoma (PDAC), Locally Advanced and Metastatic Pancreatic CancerArmsNALIRIFOX+Adebrelimab, PULSAR
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Young-Bin ChoDepartment of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, United States of America.ORCID 0000-0002-0072-9665
Nara YoonDepartmentof Mathematics and Computer Science, Adelphi University, New York, United States of America.ORCID 0000-0001-8937-4196
John H SuhDepartment of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, United States of America.
Jacob G ScottDepartment of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, United States of America.ORCID 0000-0003-2971-7673
Cleveland Clinic · USAdelphi University · US

Funding

Translational and Clinical Trial Correlates CoreU54CA274513 · NCI · CLEVELAND CLINIC LERNER COM-CWRU · PI Timothy An-thy Chan · 2022 to 2026
$9.3M
Exploiting Ecology and Evolution to Prevent Therapy Resistance in EGFR-Driven Lung CancerR37CA244613 · NCI · CLEVELAND CLINIC LERNER COM-CWRU · PI Jacob Gardinier Scott · 2020 to 2026
$4.0M
NCI NIH HHS R37 CA244613NCI NIH HHS U54 CA274513
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

NeoplasmsAnimalsDose Fractionation, RadiationImmunityMiceRadiotherapyimmune bifurcationimmune escapeimmune trapradio immune response modellingspatially fractionated RTterminal tumor volume

Identifiers

PMID37459862
PMCPMC10409909
OpenAlexW4384500243

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.